Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype

Area of Science:

• Immunology
• Reproductive Biology
• Endocrinology

Background:

• Human chorionic gonadotropin (hCG), a key pregnancy hormone, is implicated in immune regulation.
• Preventing fetal rejection is crucial for successful pregnancy, involving complex maternal-fetal immune interactions.

Purpose of the Study:

• To investigate the role of hCG in maternal-fetal immune tolerance.
• To determine how hCG affects dendritic cell (DC) maturation and function.

Main Methods:

• Mouse bone marrow-derived dendritic cells (BMDC) and splenic DCs were treated with hCG, LPS, and IFN-gamma.
• DC maturation markers, cytokine production (IL-10, IL-12p70, TNF-alpha), MHC class II expression, and T cell proliferation were analyzed.
• IDO mRNA expression and kynurenine levels were assessed.
• DCs were differentiated in the continuous presence of hCG to study its effect on differentiation.

Main Results:

• hCG treatment, especially with LPS and IFN-gamma, modulated DC cytokine profiles (increased IL-10:IL-12p70 ratio, decreased TNF-alpha).
• hCG reduced antigen-specific T cell proliferation and MHC class II up-regulation.
• IDO mRNA and kynurenine were increased, suggesting a mechanism for suppressed T cell proliferation.
• Continuous hCG exposure during DC differentiation resulted in decreased cytokine production and T cell proliferation induction.

Conclusions:

• hCG contributes to maternal-fetal tolerance by inducing a tolerogenic phenotype in dendritic cells.
• hCG's immunoregulatory effects on DCs play a role in preventing fetal rejection during pregnancy.